Cancer clinical trials in the region Occitanie

345 currently recruiting clinical trials

Looking for clinical trials?

Clinical trial search is a complex process, with countless criteria to consider. Our AI assistant navigates this complexity with precise, expert-level analysis of the most relevant trials based on your medical profile. Our database is fully up to date, so you see only actively recruiting sites. It's fast and easy:

Create your account
Copy-paste your latest medical report
Our AI-based assistant does the rest for you

Whether you are a patient or a doctor, create an account to find and apply for the most relevant clinical trials:

Create your account

Phase 2 Bladder / Urinary Tract / Urethral cancer #NCT06172478 #2023-507641-29-00

[HERTHENA-PanTumor01] Etude sur HER3-DXd chez des sujets atteints de tumeurs solides localement avancées ou métastatiques

Carcinome urothélial

Invasive bladder cancer Upper excretory tract cancer Urethral cancer Urothelial carcinoma Locally Advanced Metastatic 1 2 3 or more Immunotherapy Chemotherapy

Systemic Treatment-Naive

9 recruiting sites

Daiichi Sankyo

Phase 2 Bladder / Urinary Tract / Urethral cancer #NCT03915678 #2023-509492-16-00

[AGADIR] ATEZOLIZUMAB associé au BDB001 et à la radiothérapie chez les patients atteints de tumeurs solides avancées - Population 5

Metastatic 1 2 3 or more Immunotherapy

Systemic Treatment-Naive

9 recruiting sites

Institut Bergonié

Phase 2 Lung cancer #NCT03915678 #2023-509492-16-00

[AGADIR] ATEZOLIZUMAB associé au BDB001 et à la radiothérapie chez les patients atteints de tumeurs solides avancées - Population 3

NSCLC (Non-Small Cell Lung Cancer) Metastatic 1 2 3 or more Immunotherapy

Systemic Treatment-Naive

8 recruiting sites

Institut Bergonié

Phase 2 Colon cancer Rectal cancer Anal cancer #NCT04954820

[ReLUTH] Évaluation du retraitement avec LUTATHERA® chez les patients présentant une nouvelle progression d'une tumeur neuroendocrine intestinale bien différenciée

Neuroendocrine tumor 1 SSTR Positive

Systemic Treatment-Naive Systemic Treatment-Naive

26 recruiting sites

Institut du Cancer de Montpellier - Val d'Aurelle

Phase 2 Colon cancer Rectal cancer Anal cancer #NCT04268121 #2024-515603-19-01

[NEONEC] Efficacité de la chimiothérapie néoadjuvante en termes de survie sans maladie chez les patients atteints de carcinomes neuroendocriniens digestifs localisés

Neuroendocrine carcinoma Localized None Systemic Treatment-Naive

10 recruiting sites

GERCOR - Groupe Coopératif Multidisciplinaire d'Oncologie

Phase 2 Breast cancer #NCT05973864 #2023-505291-30-01

[CAPPA] CAPECITABINE et PEMBROLIZUMAB chez les patientes atteintes d'un cancer du sein triple négatif après chimio-immunothérapie et chirurgie

HER2 Negative HR Negative Localized None Systemic Treatment-Naive

Surgery Immunotherapy Chemotherapy

20 recruiting sites

UNICANCER

Phase 2 Lymphoma #NCT04844866

[DALY 2-EU] Efficacité et innocuité du MB-CART2019.1 par rapport au traitement standard chez les patients atteints de lymphome

Partie II

B cell lymphoma Large B cell lymphoma Primary mediastinal lymphoma Follicular lymphoma Indolent transformed lymphoma None 1 Chemotherapy Targeted therapy

Systemic Treatment-Naive Car-T

7 recruiting sites

Miltenyi Biomedicine GmbH

Phase 2 Breast cancer Prostate cancer Colon cancer Rectal cancer Anal cancer Kidney cancer Pancreas cancer Liver and bile duct cancer Bladder / Urinary Tract / Urethral cancer Stomach and esophageal cancer Endometrial cancer Ovarian / Fallopian tubes / Peritoneum cancer Head and neck cancer Sarcoma and GIST Penile cancer and germ cell tumors Cervical / Vulvar / Vaginal cancer #NCT06760819 #2024-517419-62-00

[panSOHO] Etude sur l'efficacité du BAY2927088 et sur son innocuité chez les participants atteints d'une tumeur solide présentant des mutations activatices d'HER2

Stomach Oesogastric junction Esophagus Adenocarcinoma Intrahepatic cholangiocarcinoma Extrahepatic cholangiocarcinoma Ampullary carcinoma Gastrointestinal stromal tumor Squamous cell carcinoma Other HER2 Positive Locally Advanced Metastatic Metastatic Castration-resistant HER2 1

Systemic Treatment-Naive

6 recruiting sites

Bayer

Phase 2 Liver and bile duct cancer #NCT06254248 #2024-514400-14-00

[IMMUNO-TH] Sécurité de l'atézolizumab-bévacizumab chez les patients transplantés hépatiques atteints d'un carcinome hépatocellulaire avancé

Hepatocellular carcinoma Locally Advanced Metastatic Unhealthy A None Transplant Systemic Treatment-Naive

10 recruiting sites

Assistance Publique - Hôpitaux de Paris

Phase 2 Penile cancer and germ cell tumors #NCT05529251 #2024-514636-25-00

[EDEN] Étude de désescalade pour les séminomes de stade IIa/IIb < 3 cm

Germ cell tumor Pure seminoma Locally Advanced None Systemic Treatment-Naive Testis Good prognosis

Surgery Radiotherapy Chemotherapy Radiotherapy

11 recruiting sites

Centre Léon Bérard